fbpx

DAY 1

Wednesday Oct. 6

10:00 AM - 10:15 AM: Welcome from the PEDS Chairs

  • Brenda Weigel, MD, MSc, University of Minnesota

  • Sam Blackman, MD, Day One Biopharmaceuticals

10:15 AM - 12:30 PM: Expanding the Global Footprint of Pediatric Oncology Trials

  • Chair: Sabine Mueller, MD, PhD, University of California, San Francisco

12:30 PM –1:15 PM ET: Break for Lunch

1:15 PM - 3:00 PM: Real-World Data and Synthetic Control Arms

    •  Chair: Peter Adamson, MD, Sanofi

    •  Speaker: Pallavi Mishra-Kalyani, Biostatistician at the FDA  

DAY 2

Thursday, Oct. 7

10:00 AM - 11:45 AM: Pharmacokinetics in pediatric clinical trial design: How do we find the “right” dose?

Chairs

    • Lou Stancato, PhD, Eli Lilly and Company

    • Elizabeth Fox, MD, MS, St. Jude Children's Research Hospital

11:45 AM - 12:15 PM: Break and Virtual Networking

12:15 PM - 1:15PM: Keynote: The Path of a Pediatric Targeted Therapy Through Drug Development 

    • Chair: Elly Barry, MD, MMSc, Vice President of Clinical Development, Day One Biopharmaceuticals 

1:15 PM - 3:00 PM: Clinical Trials with Combination Therapies

    • Chair: Mark Kieran, MD, PhD Bristol Myers Squibb

DAY 3

Friday, Oct. 8

11:00 AM - 12:45 PM: Decentralized Clinical Trials

    • Chair: Mark Turner, BSc, PhD, MBChB, MRCP(UK), MRCPCH, DRCOG, FFPM(Hon), University of Liverpool, conect4children

12:45 PM - 1:00 PM: Break and Virtual Networking

1:00 PM - 2:00 PM: Regulators Dish

  • PEDS Co-Chairs will discuss PEDS topics with regulators from the U.S. FDA and EMA

2:00 PM - 2:30 PM: Closing Remarks from the PEDS Chairs

  • Samuel Blackman, MD, Day One Biopharmaceuticals

  • Brenda Weigel, MD, MSc, University of Minnesota

All times listed are in Eastern Standard Time (EST).

Pin It on Pinterest

Scroll to Top